Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Advanced Therapies Week 2022 | Looking forward to Advanced Therapies Week 2022

Janet Lynch Lambert • 26 Jan 2022
Advanced Therapies Week 2022
General

Janet Lynch Lambert, CEO, Alliance for Regenerative Medicine, Washington, D.C., shares her excitement towards meeting colleagues and learning about the latest scientific advances at the Advanced Therapies Week 2022, in particular in in vivo gene editing and in vivo chimeric antigen receptor (CAR) T-cells. This interview took place at Advanced Therapies Week 2022.

Disclosures

Janet Lynch Lambert is the CEO of Alliance for Regenerative Medicine.

More from Janet Lynch Lambert

0:52
A 2022 update of the Alliance for Regenerative Medicine
Janet Lynch Lambert • 26 Jan 2022
3:07
Addressing issues in the clinical translation of cell & gene therapies
Janet Lynch Lambert • 26 Jan 2022
2:39
The GROW Internship Program: Improving the representation of Black employees within the CGT field
Janet Lynch Lambert • 26 Jan 2022

Related Videos

0:55
Multivalent gamma-delta T-cells: promising agents for the treatment of cancers
Jürgen Kuball • 10 Feb 2023
1:26
Rapid CAR-T manufacturing and challenges in this space
Nina Worel • 9 Feb 2023
1:13
An insight into novel third-generation TLR2 co-stimulatory CAR-T cells
Yasmin Nouri • 9 Feb 2023
2:08
Streamlining cell therapy manufacturing with CliniMACS Prodigy
Saskia Rösch • 6 Apr 2022
The content of VJRegenMed is intended for healthcare professionals